Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare induction chemotherapy (gemcitabine+cisplatin) plus
concurrent chemoradiotherapy (CCRT) with CCRT alone in patients with locoregionally advanced
nasopharyngeal carcinoma(NPC), in order to confirm the value of induction chemotherapy in NPC
patients.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Affiliated Cancer Hospital of Shantou University Medical College Cancer Hospital of Guangxi Medical University Cancer Hospital of Guizhou Province Cancer Hospital of Shantou University Fifth Affiliated Hospital, Sun Yat-Sen University First People's Hospital of Foshan Fourth Military Medical University Fudan University Jiangxi Provincial Cancer Hospital Peking University Tongji Hospital West China Hospital Wuhan Union Hospital, China Xijing hospital of The fourth military medical university Zhejiang Cancer Hospital